Pharma-Bio Serv, Inc. (PBSV)
|Net Income (ttm)||1.79M|
|Trading Day||June 10|
|Day's Range||1.28 - 1.28|
|52-Week Range||0.72 - 1.87|
DORADO, PUERTO RICO / ACCESSWIRE / March 17, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting f...
Pharma-Bio Serv Announces Appointment of Kirk Michel as Chairman of the Board of Directors and Announces Special Divi...
DORADO, PUERTO RICO / ACCESSWIRE / January 5, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting ...
Pharma-Bio Serv is a cheap stock based on EV/EBIT with good earnings quality based on various multi-year metrics.
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil. The company's technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto ... [Read more...]
Health Information Services
|Stock Exchange |
|Ticker Symbol |
In 2020, PBSV's revenue was $21.56 million, an increase of 10.55% compared to the previous year's $19.51 million. Earnings were $2.05 million, a decrease of -1.74%.
The average 12-month stock price forecast for PBSV is 2.11, which is an increase of 65.49% from the latest price.